Video

Better Prostate Cancer Screening for Younger African American Men May Improve Outcomes

Author(s):

Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.

Prostate-specific antigen (PSA) screening and early prostate cancer detection may improve outcomes in younger African American men, according to findings presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.

The guidelines for age to start screenings vary by organization. The U.S. Preventive Services Task Force (USPSTF) recommends selectively offering screening for individual patients based on professional judgment or patient preferences at age 55, while the National Comprehensive Cancer Network (NCCN) encourages providers to begin the discussion with patients aged 40 and above for BRCA2 mutation carriers.

“We saw that there was just this big discordance between one, age at screening, and two, how frequently to screen,” said Edmund Qiao, fourth-year medical student at the University of California San Diego and lead study author, in an interview with CURE®. “And so we want to provide some more data in terms of allowing clinicians to better guide their discussions with patients, especially young African American men, when starting the discussion about PSA screening initiation.”

Transcription:

We kind of realized that there was a big discordance in terms of PSA screening recommendations for young African American men. So there's a lot of medical societies out there, including the USPSTF, the (American Urological Association) and the NCCN, who put forward these guidelines for clinicians in terms of like when to start screening patients. And so we saw that there was just this big discordance between one, age at screening, and two, how frequently to screen. And so we want to provide some more data in terms of allowing clinicians to better guide their discussions with patients, especially young African American men, when starting the discussion about PSA screening initiation.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Image of man with black hair.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of man with brown and grey hair.
Dr. Kelly Stratton
Related Content